Kaczmarek Lukasz, Luniewski Wojciech, Zagrodzki Bogdan, Godlewska Joanna, Osiadacz Jarosław, Wietrzyk Joanna, Opolski Adam, Peczyńska-Czoch Wanda
Pharmaceutical Research Institute, Warszawa, Poland.
Acta Pol Pharm. 2002 May-Jun;59(3):199-207.
A systematic investigation into the impact of the substituents introduced into the indolo[2,3-b]quinoline system is described. The findings clearly demonstrate that the compounds bearing a methyl group or a longer aliphatic chain at the N-6 position are inactive against prokaryotic and eukaryotic cells. The introduction of alkyl-amino-alkyl substituent at the N-6 position of indolo[2,3-b]quinoline accounts for the appearance of the antimicrobial and.cytotoxic properties. The cytotoxicity against oral epidermoid carcinoma KB (ID50) is in the range from 2.0 to 9.0 microM, and the antimicrobial activity (MIC) falls between 0.03 and 0.50 mM. The structural relation within 6H-indolo[2,3-b]quinolines, concerning their antimicrobial and cytotoxic activity, corresponds well with their ability to bind DNA and to inhibit topoisomerase II activity.
本文描述了对引入吲哚并[2,3 - b]喹啉体系的取代基影响的系统研究。研究结果清楚地表明,在N - 6位带有甲基或更长脂肪链的化合物对原核细胞和真核细胞无活性。在吲哚并[2,3 - b]喹啉的N - 6位引入烷基 - 氨基 - 烷基取代基导致了抗菌和细胞毒性特性的出现。对口腔表皮样癌KB细胞的细胞毒性(ID50)在2.0至9.0微摩尔范围内,抗菌活性(MIC)在0.03至0.50毫摩尔之间。6H - 吲哚并[2,3 - b]喹啉类化合物的抗菌和细胞毒性活性与其结合DNA和抑制拓扑异构酶II活性的能力之间的结构关系非常吻合。